Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,138 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

NCT00000794

Conditions
Abscess, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +29 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Queens Med. Ctr. Honolulu, Hawaii, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View all 16 locations
View Trial Details
Completed

A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

NCT00000880

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
View Trial Details
Completed

A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients

NCT00000863

Conditions
AIDS-Related Opportunistic Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Queens Med. Ctr. Honolulu, Hawaii, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
  • Northwestern University CRS Chicago, Illinois, United States
View Trial Details
Completed

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

NCT00000815

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 46 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

NCT00000855

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham - Pediatric Birmingham, Alabama, United States
  • Phoenix Childrens Hosp Phoenix, Arizona, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 36 locations
View Trial Details
Completed

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

NCT00000750

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • Kaiser Permanente / UCLA Med Ctr Downey, California, United States
  • UCLA Med Ctr / Pediatric Los Angeles, California, United States
  • Harbor - UCLA Med Ctr / UCLA School of Medicine Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States
View Trial Details
Completed

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

NCT00000865

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States
  • Bronx-Lebanon Hosp. IMPAACT CRS The Bronx, New York, United States
View Trial Details

Related conditions